Abingdon Health Plc (LSE: ABDX) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ABDXAbingdon Health Plc

LSE · GB · Healthcare · Diagnostics & Research · abingdonhealth.com

10.25GBp0.00%Mkt Cap: 27.97M $P/E: —1d ago

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…

Industry Peers

Diagnostics & Research

vs Diagnostics & Research

P/B

Pricier

1M Perf

Higher

Thermo Fisher Scientific Inc.

$186.32BUSDP/E 27.6

Danaher Corporation

$134.82BUSDP/E 36.8

$43.51BUSDP/E 42.0

IDEXX Laboratories, Inc.

$41.53BUSDP/E 38.7

Agilent Technologies, Inc.

$37.53BUSDP/E 26.7

Waters Corporation

$36.82BUSDP/E 47.7

IQVIA Holdings Inc.

$32.25BUSDP/E 24.0

$26.60BUSDP/E 31.9

Mettler-Toledo International Inc.

$25.82BUSDP/E 30.0

Quest Diagnostics Incorporated

$23.46BUSDP/E 23.4

Labcorp Holdings Inc.

$22.96BUSDP/E 24.8

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.12BUSDP/E 33.3

Eurofins Scientific SE

$12.91BUSDP/E 26.9

$12.41BUSDP/E 53.5

Charles River Laboratories International, Inc.

bioMérieux S.A.

$8.81BUSDP/E 20.6

Twist Bioscience Corporation

BillionToOne, Inc.

$5.52BUSDP/E 222.2

Sotera Health Company

$5.06BUSDP/E 43.3

$4.69BUSDP/E 54.4

DiaSorin S.p.A.

$3.65BUSDP/E 25.7

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.48BUSDP/E 37.4

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Personalis, Inc.

OPKO Health, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

Castle Biosciences, Inc.

$615.20MUSDP/E 40.1

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.38MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Eurofins-Cerep SA

$94.30MUSDP/E 18.2

Pangaea Oncology, S.A.

Immunovia AB (publ)

$10.07MUSDP/E 63.2

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Oxford BioDynamics Plc

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap27.97M $

Enterprise Value45.29M $

Revenue (TTM)10.40M $

Gross Profit4.06M $

Net Income (TTM)-3.71M $

Revenue/Share0.0272 USD

Last Price10.25 GBp

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees129

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)68.33

PEG—

EV/EBITDA-12.18

EV/Revenue4.35

P/S2.69

P/B6.83

EPS (TTM)-0.01

EPS (Forward)0.00

52W Range

0.000079% of range13.00

52W High13.00 GBp

52W Low0.0000 GBp

Profitability

Gross Margin44.32%

Oper. Margin-53.88%

EBITDA Margin-35.73%

Profit Margin-40.51%

ROE-64.43%

ROA-36.67%

Growth

Revenue Growth36.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.46M $

CapEx (TTM)376.09K $

FCF Margin-15.34%

FCF Yield-5.71%

Net Debt-3.00M $

Net Debt/EBITDA0.81

Balance Sheet

Debt/Equity0.19

Current Ratio1.91

Quick Ratio1.73

Book Value/Sh0.0150 GBp

Cash/Share0.0090 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)19.00 GBp

Upside (mean)+85.4%

Target Range19.00 GBp – 19.00 GBp

# Analysts1

Ownership

Shares Out.251.08M

Float168.65M

Insiders30.84%

Institutions31.56%

Technical

SMA 5011.26 (-8.9%)

SMA 2007.913 (+29.5%)

Beta0.18

S&P 52W Chg20.05%

Avg Vol (30d)207.89K

Avg Vol (10d)157.92K

Technical Indicators

RSI (14)32.2

MACD-0.2438

MACD Signal0.0055

MACD Hist.-0.2493

BB Upper13.16 GBp

BB Middle11.64 GBp

BB Lower10.12 GBp

BB Width26.13%

ATR (14)1.004 GBp

Vol Ratio (20d)0.29x